Article info
PDFOriginal articles
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
- Correspondence to Dr Valerio Nobili, Unit of Metabolic and Autoimmune Liver Diseases, “Bambino Gesù” Children's Hospital – IRCCS, Square S Onofrio 4, 00165 Rome, Italy; nobili66{at}yahoo.it
Citation
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
Publication history
- Accepted November 8, 2010
- First published January 12, 2011.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions